Policy paper

Statement on arrangements for pricing branded medicines from 2014

This publication was published under the 2010 to 2015 Conservative and Liberal Democrat coalition government

The Association of the British Pharmaceutical Industry and the Department of Health have published a Joint DH/ABPI statement

Document

Detail

The negotiations, which are set to begin in September, will determine the arrangements for pricing branded medicines in the UK from 2014, including medicines that are already on the market in December 2013 and new medicines which are launched from January 1 2014.